Loss of miR-145 promotes remyelination in a chronically demyelinated animal model, implicating it as a factor in remyelination failure in human Multiple Sclerosis lesions and highlighting in as a potential therapeutic target for progressive MS.
- Samantha F. Kornfeld
- Sarah E. Cummings
- Rashmi Kothary